ezetimibe has been researched along with bupropion in 4 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (bupropion) | Trials (bupropion) | Recent Studies (post-2010) (bupropion) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 3,392 | 755 | 1,329 |
Protein | Taxonomy | ezetimibe (IC50) | bupropion (IC50) |
---|---|---|---|
Acetylcholine receptor subunit alpha | Homo sapiens (human) | 5.2693 | |
Acetylcholine receptor subunit gamma | Homo sapiens (human) | 5.2693 | |
Integrin alpha-5 | Homo sapiens (human) | 1.8 | |
Acetylcholine receptor subunit beta | Homo sapiens (human) | 5.2693 | |
Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | 0.9373 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.2003 | |
Neuronal acetylcholine receptor subunit beta-4 | Homo sapiens (human) | 1.2028 | |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens (human) | 1.367 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 1.9983 | |
Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | 7.9 | |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | 0.0135 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.0848 | |
Acetylcholine receptor subunit delta | Homo sapiens (human) | 5.2693 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Buckley, DB; Kazmi, F; Ogilvie, BW; Paris, BL; Parkinson, A; Yerino, P | 1 |
2 review(s) available for ezetimibe and bupropion
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes.
Topics: Azetidines; Bupropion; Cytochrome P-450 Enzyme Inhibitors; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Ezetimibe; Gemfibrozil; Glucuronosyltransferase; Hepatocytes; Humans; Microsomes, Liver; Recombinant Proteins | 2010 |
2 other study(ies) available for ezetimibe and bupropion
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |